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Proving that a gene unit is totally nonfunctional, and is therefore definitely a pseudogene, 
is impossible.          
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ABSTRACT  
Traditionally, pseudogenes have been regarded as “dead” gene copies as a result of features such as 
the absence of promoters and the existence of premature stop codons. However, the recognition of a 
truly disabled gene is not as straightforward as once believed. It is now known that promoters may be 
cryptic. Genomic recoding processes can allow for the synthesis of a peptide despite the present of 
premature stop codons. Alternative splicing can allow for the omission of exons that contain premature 
stop codons. Finally, negative evidence for pseudogene expression, for the relatively few pseudogenes 
for which it is available, must be interpreted with caution. This is in view of the fact that many genes 
express themselves only under very restricted conditions. 
 
INTRODUCTION 
Each component of the eukaryotic gene plays a role in its expression. The DNA sequence of the gene 
that is transcribed into mRNA and then translated into a protein (in the case of protein-coding genes) is 
called the open reading frame. The promoter indicates the approximate location where transcription is to 
begin while the polyadenylation signal terminates the transcription. Some genes have both exons and 
introns, and these are marked off by splice sites. The primary RNA transcript includes both exons and 
introns, but the latter are spliced out in the mature mRNA.  A translation initiation codon signals the 
location where the mature mRNA is to be translated into a peptide, while the stop codon terminates the 
translation process.  
 
In many genes, features such as the promoter and initiation codons can be recognized solely by 
inspection of the gene’s DNA sequence, and gene-search computer algorithms have been designed and 
used to exploit this fact. However, it is commonly acknowledged that an unknown fraction of genes is 
missed by such algorithms as a result of unconventional genes whose sequences deviate in some 
important-but presently unknown-way from canonical genes. Such genes can only be discovered 
through traditional genetics or biochemistry. 
 
Three decades ago, Susumu Ohno, a prominent Japanese geneticist, suggested that noncoding DNA 
lacks function, and originates from the remnants of dysfunctional genes. In fact, by analogy to the fossils 
found in the Earth’s crust, he called them fossilized genes [51, 37]. In time, “dead” gene copies came to 
be called pseudogenes. They clearly resemble specific genes but seem to be disabled as a result of 
inferred mutational lesions: 
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Almost any imaginable defect can be found in pseudogenes, including abnormal initiation 
and termination codons, altered normally invariant codons, deletons, insertions, and 
nonsense mutations, as well as defects in promoter, RNA splicing, and polyadenylation 
sequences. [33, p. 253] 
Pseudogenes are often more dissimilar from their certainly functional paralogs than the latter are from 
each other. This sequence diversity is interpreted as indicative of the fact that purifying selection is not 
acting to eliminate mutations from these putatively untranscribed  gene-like sequences.  Finally, 
pseudogenes at first were not observed to be transcribed nor translated in standard cell biology assays. 
All of this led to the belief that they are simply disabled copies of genes.  
 
This thinking was perhaps reasonable some twenty years ago. However, advances in genomic 
knowledge now complicate the identification of pseudogenes. Features such as genomic recoding, 
alternative splicing, and cryptic promoters provide evidence that some apparent lesions, as occur in 
pseudogenes, can be over-ridden. Moreover, this over-riding can be regulatory as well as reparative in 
nature.   
 
Pseudogenes have been exploited by opponents of special creation. The existence of seemingly 
disabled gene copies, notably in human genomes, have been taken as evidence against the design of 
genomes by a Designer. In addition, some of the apparent disablements found in pseudogenes have 
been found to be shared by humans and apes, prompting the argument that only shared common 
descent could account for these “shared mistakes” [43]. There is no shortage of anti-creationists who 
have repeated this assertion. However, the “shared mistake” argument is a dubious one. It ignores or 
belittles the fact that pseudogenes can acquire identical “lesions” independently [70].  If it turns out that 
pseudogenes are not disabled genes after all, the “shared mistake” argument would become all but 
moot.  
 
Owing to the breadth of this topic, a series of papers is planned which address pseudogene-related 
phenomena. There are two main types of pseudogenes: classical and processed (the latter also called 
retropseudogenes). Interpersed repeats, considered by some to be retropseudogenes, are not 
discussed in this work. This paper emphasizes classical pseudogenes, although most of the discussion 
is also applicable to retropseudogenes. Consideration of pseudogene features themselves is limited to 
absent or disabled promoters, and to premature stop codons.  Throughout this work, the emphasis is on 
eukaryotic genomes, and on the similarities which they share. In fact, in this regard, Resnick and Cox 
[55], in all seriousness, call yeast an honorary mammal.  
 
DIVERSITY OF PROMOTERS PREVENTS READY IDENTIFICATION  
Early studies of genes had indicated that certain conserved sequences are responsible for transcription. 
Because such regulatory sequences can be experimentally inactivated by artificial mutation, it is 
commonly assumed that inferred natural mutations of regulatory sequences will have an identical effect, 
transcriptionally silencing an otherwise active gene. However, even an obvious alteration of normally 
conserved gene transcription elements does not necessarily imply their inactivation. The γ-globin tarsier 
pseudogene was once “pronounced dead” solely because the distal CCAAT box was missing, and the 
second one had an ostensibly inactivating mutation (CcgAT). Now the γ-globin pseudogene is believed 
to be functional based on the absence of nonsynonymous substitutions in the coding regions [44], 
although the role of this sequence needs to be clarified. 
 
The foregoing discussion is especially applicable to promoters, which are at the very core of the 
transcription process. A functional promoter is required for transcription of a gene to begin. Inferences 
are commonly made about the putative mutational inactivation of promoters in classical pseudogenes 
and the absence of promoters in retropseudogenes. However, determining whether or not some kind of 
functional promoter exists is no longer straightforward.   
 
The most commonly occurring promoter complex includes the TATA box, which is usually situated about 
30 nucleotides upstream of the translation start site (though it will still function as close as 15 
nucleotides to the same: [52]). The TATA motif itself is an idealization, as it actually subsumes a large 
diversity of AT-rich short sequences [5]. Moreover, the TATA box can turn up in unexpected locations, 
even within the gene’s coding region [50].  
 
We now realize that a variety of non-TATA sequences can function as promoters from the same 30 
nucleotide distance [69]. Furthermore, in compositional contrast to the AT-rich TATA-type promoters, 
GC-rich promoters also exist for a significant number of genes. They can be found embedded within 
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CpG islands, occurring at variable distances from genes and sometimes even serving two genes 
simultaneously [39]. It is significant that an increasing number of short nucleotide sequences are being 
discovered that exhibit previously unsuspected promoter activity [59, 64]. These aptly named cryptic 
promoters are more prevalent than previously supposed [75, p. 7373]. And, contrary to earlier beliefs, 
neither the TBP nor the TFIID transcription factors need be present to bind to whatever promoter sites 
there are in existence, as other TAFIIS can perform this role [68].  This further complicates our 
understanding of promoter sequences.  
 
Functional promoters can be difficult to identify because some of them regulate genes from a 
considerable distance [63]. Moreover, some promoter sequences display little activity unless they work 
together with enhancers. The latter, in turn, are especially difficult to identify because they are quite 
variable in sequence and may be located at considerable distances from the promoter [28].  In fact, 
enhancers and other gene regulatory elements that are situated hundreds of kilobases from the 
promoter may be unexpectedly common [9].  
 
It is a fairly common practice to compare pseudogenes with their gene paralogs, and then suspect that 
the pseudogene is transcriptionally inert owing to the fact that its promoter region differs significantly 
from that of its gene paralog, and the promoter is therefore presumably nonexistent or disabled. 
However, it is certainly possible that an apparently retrotranscribed gene could be under the control of 
an uncharacterized promoter. Such is the case for the human and rodent Supt4h and Supt4h2 genes, 
prompting this comment: 
This illustrates another potential complexity of the mammalian genome, i. e., the use of a 
processed gene under the control of a different promoter region than the unspliced gene. 
[7, p. 4960] 
It is commonly supposed that, keeping in mind the usual loss of the promoter sequence during reverse 
transcription, it is very unlikely that a retroposited gene sequence would fortuitously land near a suitable 
pre-existing promoter. However, it is sobering to realize that, at least in yeast, 1% of randomly chosen 
16bp DNA sequences can function as promoters at an equal or better rate than the canonical TATA box 
[60]!  And this does not consider weaker potential promoter sequences, at least some of which could 
serve as promoters if they happen to be paired with suitable enhancers, which, as noted earlier, may 
influence the promoter from a considerable distance. 
  
Judgments about absent or damaged promoters must be re-examined in the light of the fact that 
unexpectedly many genes have more than one promoter [1]. As an example, the experimental removal 
of the entire 250 bp proximal promoter region (including the TATA box) of the human K18 gene fails to 
silence the gene. It only causes the activation of a second (“Lazarus”) promoter [57]. The implication of 
plural promoters for the avoidance of gene inactivation is recognized: 
Alternatively, initiation of transcription at several sites, generating transcripts differing only 
in their 5’-untranslated region, might render expression of the gene less vulnerable to 
mutations in promoter sites. [1, p. 456] 
The N-myc2 retrosequence in the woodchuck [16] constitutes a retropseudogene that is transcribed 
thanks to a secondary promoter that had been unmasked by the reverse transcription process that 
produced this retroposon. The transcriptional activity of the secondary promoter in N-myc2 is verified 
experimentally. N-myc2 is transcribed in pathological tissue (liver tumors) as well as healthy tissue (the 
brain). Owing to the fact that the N-myc2 sequence itself appears to be conserved, N-myc2 is suspected 
of playing a biological role.  
 
The Adh retrosequences in Drosophila provide an instructive example of the fact that the absence of a 
functional promoter in a pseudogene is all but impossible to prove by examining the sequence: 
We have gathered conflicting evidence about the putative functionality of these 
retrosequences…Inspection of the 5’ region flanking the Adh retrosequences of the 
obscura species did not show any remnant similar to the original promoter sequences or 
structural homologies with an already-identified coding sequence. Nevertheless, we cannot 
discard the idea that these retrosequences might have captured a new promoter and might 
be transcribed. [41, p.  1323] 
Since very few “promoter damaged” or “promoterless” pseudogenes have been experimentally 
investigated for cryptic promotjjjer or secondary promoter activity, we cannot assume that they are 
transcriptionally inert. Finally, it must be recognized that a significant number of pseudogenes have been 
found to be transcriptionally active after all. However, “The functional relevance of pseudogene 
transcripts remains unclear” [46, p. 112].   
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INFERRING TRANSLATION-PREVENTING MUTATIONS 
If a pseudogene can be transcribed, the next question concerns its capability for translation. Various 
transcribed pseudogenes seem untranslatable because an initiator codon (usually AUG) is putatively 
absent. However, some investigators [34] recognize the fact that the pseudogenes under study may in 
fact be able to undergo translation initiation, and therefore potentially code a functional product, because 
some alternative, downstream AUG codon can serve as the initiator. Moreover, analyses of alternative 
splicing, a genomic process now known to be common [40], demonstrate that alternative AUG start 
codons occur at a previously unsuspected high frequency in genes [47]. 
 
One form of splicing takes place in the bacterium Anaplasma phagocytophila. The p44-18 pseudogene 
lacks an AUG start codon and is out of frame with its upstream overlapping paralogous gene, p44-1. 
Thanks, however, to a splicing mechanism that excises the intervening sequence between p44-1 and 
p44-18, the apparent impediments to pseudogene expression are overcome [76].  
 
Assuming that translation initiation is possible, it is not straightforward to determine which alterations in 
the ORF would necessarily prevent the completion of the translation process : 
…it is likely that a substantial fraction of degenerative mutations (perhaps the majority) do 
not lead to complete loss-of-function (subfunctionalization), …[42, p. 470] 
As an example of this, Fletcer et. al. [15] are unsure whether they are dealing with a gene or a 
pseudogene owing to the fact that, in spite of containing many inferred missense mutations, it may still 
be capable of being translated into a variant but functional peptide. Similarly, Mezzina et . al. [45, p. 111] 
raise the following caution about a transcribed rat pseudogene: 
Nevertheless, we cannot rigorously exclude that the ΨmtTFA might have evolved to fulfill 
some alternative function, in which case, the sequence drift could be ascribed to selection 
for this alternative function rather to a lack of functionality. 
This fact can be generalized. In his comprehensive survey of functional retrosequences (including 
retropseudogenes), Brosius [4, p. 223]  alludes to the ambiguity of mutational inactivation: 
There are probably numerous additional retrogenes whose ORFs are not severely 
compromised or could yield a truncated polypeptide, partially in a different reading frame 
[Refs.]. However, transcription and/or translation are not documented. (emphasis added). 
 
Even according to evolutionary long-age assumptions, a (pseudo)gene can be undergoing an 
inferred rate of nonsynonymous to synonymous substitutions at a ratio approaching 1.0 without  
necessarily being in a “mutational freefall”. For example, some erstwhile Drosophila pseudogenes 
were subsequently promoted to at least potentially active gene status. The relatively large 
inferred rates of nonsynonymous substitutions were reinterpreted as being the outcome of 
selection pressure instead of the absence of functional constraints [53]. 
 
Many proteins contain certain domains or motifs deemed indispensable for the performance of 
their biological roles. However, we now know that these may differ between paralogous genes, or 
even between different splice variants from the same gene. Consider, for instance, the Bcl-rambo 
gene, involved in proapoptotic activities, and which contains the BH1, BH2 and BH3 motifs. The 
Bc1-rambo beta splice variant of the preceding, by contrast, lacks the foregoing domains and 
translates into a BH4-only protein. An exonized Alu insertion, containing a premature stop codon, 
is responsible for the synthesis of the domain-deprived shortened peptide [73]. Clearly, no 
pseudogene should be reckoned “dead” just because its deduced peptide sequence lacks one or 
more functional domains found in its gene paralogs. This fact can be extended to instances 
where a missing-domain deduced peptide sequence fails to closely correspond to currently 
known functional peptides: 
If the transcript from 11Ψh-mtTFA was to be translated, it would produce a protein of 89 
amino acids having 67.44% similarity with human mtTFA protein from amino acids 52-142, 
thus lacking the second HGM box and subsequently the ability to bind DNA. A Blast 
search against the SwissProt database has not revealed any other significant similarity, 
suggesting that this putative protein, if present, could have a different role from h-mtTFA 
[56. p. 231]  
 
TRANSLATION IN THE CASE OF PARTIAL OPEN READING FRAMES 
In genes exhibiting conventional behavior, the stop codon’s sole function is to give a signal for 
translation of a peptide product to terminate. A nucleotide substitution may convert an amino acid coding 
codon into a premature stop codon, or else an insertion or deletion may shift the open reading frame, 
causing a premature stop codon to come into phase with the remaining ORF. This is commonly believed 
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to indicate that any peptide, if synthesized at all, would be inert. Premature stop codons are 
characteristic of pseudogenes [11, 19], so much so that they are employed to help identify them in the 
genome [26].   
 
There are several reasons, however, for no longer accepting the premature stop codon as an ipso facto 
indicator of a pseudogene’s “dead” status. Numerous instances are now known where a truncated 
peptide, far from being inert, exhibits much the same biological activity as its full-length isoform [42, 35, 
36, 62, 66]. A premature stop codon may simply create two shorter ORFs, at least one of which may be 
translated into a viable peptide, as is the case with a shortened Drosophila kelch protein that appears 
sufficient for the insect’s development [58].  In their survey of the nematode worm's (C. elegans) 
genome, Harrison et al. [23] point out that some of their so-designated pseudogenes may actually be 
functional genes that make shortened peptides. Other investigators of pseudogenes [54] have voiced 
similar concerns.  
 
PREMATURE STOP CODONS SEEN IN A NEW LIGHT 
Since, as noted earlier, the stop codon acts to terminate peptide synthesis, it seems self evident that a 
premature stop codon necessarily indicates abnormal truncated translation. In striking opposition to this, 
various cellular processes, collectively known as recoding, are now known (see Baranov et al. [2] for 
review). Because recoding processes are known from taxonomically diverse groups, such as bacteria 
and mammals, such processes may occur in many, if not most, groups. Without recoding, most of the 
genes in question would not function properly, if at all, and would, by conventional definition, be 
pseudogenes.  
 
One notable recoding process is codon redefinition, which allows a certain codon to possess an 
alternative mode of expression. Pointedly, codon redefinition allows for the premature stop codon to be 
read-through so that the (pseud)ogene can complete the translation of a full-length peptide. Some forms 
of readthrough are able to “over-rule” all three possible premature stop codons [62]. Those ORFs in 
yeast genes that are subject to readthrough have explicitly been referred to as containing pseudogenic 
features by Harrison et al. [25]. In certain yeast genes, readthrough of premature stop codons is said to 
be fairly common [35]. Certain prions, responding to environmental stress, can activate a seemingly-
disabled yeast (pseudo)gene by readthough of its premature stop codon: 
Clearly, the lethal consequences of a nonsense mutation in an essential gene would be 
overcome in an allosuppressor background. [PSI+]  is an omnipotent allosuppressor 
determinant, in that it enhances nonsense suppression of all three termination codons… 
[10, p. 1978]  
The foregoing example is recognized by Harrison and Gerstein [24] as a process for “resurrecting” 
disabled genes. Other investigators [31, 32] are unsure whether they are dealing with a gene or a 
pseudogene because of the recently appreciated ambiguity of the effects of premature stop codons.  
 
In their investigation of pseudogenes in E. coli, Homma et al. [30] acknowledge the possibility of 
recoding processes, but suggest that their (apparent) rarity makes them “…unlikely to be operative in 
many of the pseudogene candidates:” However, sweeping generalizations about the rarity of recoding 
processes may be unwarranted. Hammell et. al. [22] have found that 2.54% of yeast genes have the 
distinctive heptamer sequence that is known to serve as a –1 ribosomal frameshift signal. Furthermore, 
the apparent overall infrequency of recoding processes owes at least partly to research biases favoring 
highly expressed, well-studied, canonically behaved genes [18]. Finally, we do not know the extent of 
recoding processes in sporadically expressed genes, let alone supposed pseudogenes.   
 
Some forms of translational readthrough are rather surprising. The premature stop codon is now known 
to function as a “wild card” codon for specifying noncanonical amino acids, namely selenocysteine [29] 
and possibly L-pyrrolysine [61]. The amino acid “alphabet” turns out to be larger than conventionally 
believed. No one knows how many other rarely occurring amino acids are, or were, encoded by 
otherwise pseudogenic premature stop codons. 
 
Finally, even if all of the above-discussed factors are not applicable to a pseudogene with a premature 
stop codon, this still does not guarantee its “dead” status, thanks to alternative splicing. Morgan et. al. 
[48] have recently pointed out that this process has not been explored in detail even in certain highly-
expressed genes.  Yousef et al. [74] caution that there may be functional splice variants of the human 
siglec pseudogenes that are expressed only in certain tissues, certain developmental stages, or 
pathological situations, or which can encode a truncated, yet functional peptide. This fact can now be 
generalized. Thus, Harrison et al. [27] point out that it is now actually difficult to distinguish a functional 
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gene from a nonprocessed pseudogene by inspection of the DNA sequence, all because an exon 
containing a perceived disablement may be spliced out and the remaining transcript then translated into 
a functional product. 
 
ASSESSING THE EXPRESSION OF GENES AND PSEUDOGENES 
Up to this point, discussion has been limited to the inference of potential pseudogene expression from 
DNA sequence alone. It is clear that there are numerous difficulties in determining whether or not a 
gene-like structure is biologically active. Consider, first of all, human genes in general: 
Even with genome sequences in hand, our ability to identify genes is largely limited to 
relatively large, evolutionarily conserved, moderately to highly expressed protein coding 
genes. We know there are exceptions that fly below our radar—tiny genes, rapidly evolving 
genes, genes expressed in only a few cells at special times—but we had hoped, with some 
justification, that they aren’t too important or numerous [12, p. 137]  
To the contrary, such rarely expressed genes may be numerous [14], and expressed only at low levels 
[72, p. 811]. Large-scale surveys of mRNA sequences (EST libraries) have their own biases [40]. For 
instance, they typically contain very few transcripts that have a low copy number or short half-life. 
Pointedly, comparable characteristics may hold for most products of pseudogene expression. This 
would especially include those situations where only a small part of the pseudogene’s sequence ever 
becomes translated. Gene-search algorithms are particularly weak in this regard: 
There exist two basic problems in gene recognition: recognition of protein coding regions 
and recognition of the functional sites of genes. They are not yet satisfactorily solved, 
especially in recognizing shorter coding regions of human genes…When sequences are 
shortened, the difference of statistical characteristics between coding and noncoding 
sequences tend to be small. [67, p. 207, 211] 
As for pseudogene sequences themselves, there is no foolproof correlation between the number of 
“disablements” in a pseudogene, and whether or not, at minimum, it turns out to be transcribed. Harrison 
et al. [25] have found expressed ORFs in yeast genes in spite of these having at least five “lesions.” The 
D2 pseudogene is transcribed in the ovary although it has seven lesions, excluding missense mutations 
[8].   
  
Having seen the inadequacy of inferential judgments of pseudogene viability, let us now consider actual 
in vitro and in vivo experiments regarding the same. It turns out that many pseudogenes, inert according 
to initial experiments, turn out to be transcribed after all [3]. Some are eventually found expressed only 
in a few tissues [31, 32], including particular tissues in which other investigations had failed to detect any 
expression [8, 13]. Various researchers [21, 46] caution that silence of a tested pseudogene may only 
indicate that the minimal conditions for expression have not been met during the test. In like manner, 
negative evidence of pseudogene translation can hardly be called conclusive. Note that any synthesized 
peptide may degrade too rapidly for detection [20] and/or be translated in cell lines, tissues, or 
developmental stages missed by experimental analyses [17]. 
 
It is an intriguing fact that, at least in the nematode C. elegans, genes involved in early development 
have significantly more paralogous pseudogenes than those expressed in the later stages of the worm’s 
life [6]. Might this imply at least a one-time expression of pseudogenes in the early development of an 
organism? Pointedly, Fourel et al. [16] caution that their failure to observe the N-myc2 (pseudo)gene 
expressing itself in fetal tissue does not exclude its potential expression in stem cell tissue. Owing to the 
fact that only a vanishing number of pseudogenes have been tested for expression in stem cell tissue, 
this takes on further significance.  
 
CONCLUSIONS 
Genes are much more complex than believed until recently, and we know much less about them than 
we thought we did. Many genes do not behave in a straightforward, canonical manner. It is obvious that 
the conventional gene/pseudogene demarcation is becoming more and more difficult to draw. More and 
more (pseudo)genes with apparent lesions turn out to be transcribed and even translated. Sweeping 
assertions about the nonfunctionality of pseudogenes [43] appear to be more and more dubious.  
 
When pseudogenes are studied as a whole, it is almost always from the assumption of biological 
inactivity and neutral molecular evolution [23]. Personal discussions with genomic specialists have 
revealed the sobering fact that no one has examined pseudogenes for expression in a comprehensive 
and systematic manner. All research is paradigm driven, and there is a disinclination to study objects 
that are deemed relatively unimportant within the scope of the ruling paradigm. Add to this the fact that 
the biotech industry prefers to allocate funding to the study of interesting genes in preference to the 
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decoding of junk DNA [37, p. 1125]. It is time for pseudogenes to be systematically tested for biological 
expression.  
 
No attempt has been made in this paper to examine all pseudogene-related phenomena, nor to present 
a scientific creationist hypothesis for their origin. However, the fact that some genes have apparent 
lesions that actually serve regulatory purposes (as in recoding) allows one to consider at least some 
pseudogenes as a type of highly-regulated noncanonical gene. These could have been specially created 
with the pseudo-lesions serving as regulators of transcription and/or translation. Further creationist 
research on pseudogenes should not only include systematic investigation of their expression, in all 
tissues, but also of the relationship of pseudogenes to recoding processes. Studies should also be 
undertaken on the potential function of pseudogenic transcripts and truncated proteins, both of which 





Standard PubMed Journal Abbreviations Are in Use. 
 
[1] Ayoubi, T. A. Y, and W. J. M. van de Ven. Regulation of gene expression by alternative 
promoters. FASEB J 10, (1996) 453-460. 
 
[2] Baranov, P. V., et al. Recoding: translational bifurcations in gene expression. Gene 286, 
(2002) 187-201.  
 
[3] Betran, E., et al. Evolution of the Phosphoglycerate mutase processed gene in human and 
chimpanzee revealing the origin of a new primate gene.  Mol Biol Evol 19(2002)654-663. 
 
[4] Brosius, J. Genomes were forged by massive bombardments with retroelements and 
retrosequences. Genetica 107, (1999) 209-238. 
 
[5] Burke, T. W. et al. The DPE, a conserved downstream core promoter element that is 
functionally analogous to the TATA box. Cold Spring Harb Symp Quant Biol 63, (1998) 75-82. 
 
[6] Castillo-Davis, C. I., and D. L. Hartl. Genome evolution and developmental constraint in 
Caenorhabdities elegans. Mol Biol Evol 19, (2002) 728-735.  
 
[7] Chiang, P.-W. et al. Comparison of murine Supt4h and a nearly identical expressed, 
processed gene. Nucleic Acids Res 26, (1998) 4960-4964. 
 
[8] Choi, D. et al. The expression of pseudogene cyclin D2 mRNA. J Assist Reprod Genet 18, 
(2001) 110-113. 
 
[9] DiLeone, R. J., et al. An extensive 3’ regulatory region controls expression of Bmp5 in 
specific anatomical structures of the mouse embryo. Genetics 148, (1998) 401-408. 
 
[10] Eaglestone, S. S. Translation termination efficiency can be regulated by Saccharomyces 
cerevisiae. Embo J 19, (1999) 1974-1981. 
 
[11] Echols, N., et al. Comprehensive analysis of amino acid and nucleotide composition of 
eukaryotic genomes, comparing genes and pseudogenes. Nucleic Acids Res 30, (2002), 
2515-2523. 
 
[12] Eddy, S. R. Computational genomics of noncoding RNA genes. Cell 109:137-140. 
 
[13] Endrizzi, K., et al. Discriminative quantification of cytochrome P4502D6 and 2D7/8 
pseudogene expression by TaqMan real-time reverse transcriptase polymerase chain 
reaction. Anal Biochem 300, (2002) 121-131.  
  
[14] Ewing, B, and P. Green. Analysis of expressed sequence tags indicates 35,000 human 
genes. nat genet 25, (2000) 232-240.  
 
 512
[15] Fletcher, B. H. et. al. The murine chaperonin 10 gene family contains an intronless, putative 
gene for early pregnancy factor, Cpn10-rs1. Mamm Genome 12, (2001) 123-140. 
 
[16] Fourel, G., et al. Expression of the woodchuck N-myc2 retroposon in brain and in liver 
tumors is driven by a cryptic N-myc2 promoter. Mol Cell Biol 12, (1992) 5336-5344. 
 
[17] Fujii, G. H. Transcriptional analysis of the PTEN/MMAC1 pseudogene, ΨPTEN. Oncogene 
18, (1999)1765-1769. 
 
[18] Gesteland, R. F., and J. F. Atkins. RECODING.  Annu Rev Biochem 65, (1996) 741-768. 
 
[19] Goncalves, I. et al. Nature and structure of human genes that generate retropseudogenes.  
Genome Res 10, (2000) 672-678. 
 
[20] Görlach, A. A p47-phox pseudogene. J Clin Invest 100, (1997) 1907-1918. 
 
[21] Gregor, P., et al. Molecular characterization of a second mouse pancreatic polypeptide. J 
Biol Chem 271, (1996) 27776-27781. 
 
[22] Hammell, A. B. et. al. Identification of putative programmed –1 ribosomal frameshift signals 
in large DNA databases, Genome Res 9, (1999) 417-427. 
 
[23] Harrison, P. M. et al. Digging for dead genes. Nucleic Acids Res 29, (2001) 818-830. 
 
[24] Harrison, P. M. and M. Gerstein. Studying genomes through the aeons. J Mol Biol 318, (2002) 
1155-1174. 
 
[25] Harrison, P. M. et al. A small reservoir of disabled ORFs in the yeast genome and its 
implications. J Mol Biol 316, (2002a) 409-419. 
 
[26] Harrison, P. M. et al. Molecular fossils in the human genome. Genome Res 12, (2002b) 272-
280. 
 
[27] Harrison, P. M. et al. A question of size: the eukaryotic proteome and the problems in 
defining it. Nucleic Acids Res 30, (2002c) 1083-1090. 
 
[28] Helden, J. van, et al. Extracting regulatory sequences from the upstream region of yeast 
genes by computational analysis of oligonucleotide frequencies. J Mol Biol 281, (1998) 827-
842. 
 
[29] Hill, K. E. et al. The cDNA for rat selenoprotein P contains 10 TGA codons in the open 
reading frame. J Biol Chem 266, (1991) 10050-10053. 
 
[30] Homma K. et al. A systematic investigation identifies a significant number of probable 
pseudogenes in the Escherichia coli genome. Gene 294, (2002) 25-33. 
 
[31] Hsu, L. C., and W.-C. Chang. Sequencing and expression of human ALDH8. Gene 174, 
(1996) 319-322. 
 
[32] Hsu, L. C., et al. Human aldehyde dehydrogenase genes.  Gene 189, (1997) 89-94. 
 
[33] Jeffreys, A. J., and S. Harris. Pseudogenes. Bioessays 1 (1984) 253-257. 
 
[34] John, T. R. et al. A phospholipase A2-like pseudogene retaining the highly conserved 
introns of Mojave toxin.  DNA Cell Biol 15, (1996) 661-668. 
 
[35] Kopczynski, J. B. Translational readthrough at nonsense mutations in the HSF1 gene. Mol 
Gen Genet 234, (1992) 369-378. 
 
[36] Kroiher, M. et al. A gene whose major transcript encodes only the substrate-binding 
domain of a protein-tyrosine kinase. Gene 241, (2000) 317-324. 
 513
 
[37] Kuska, B. Should scientists scrap the notion of junk DNA? J Natl Cancer Inst 90, (1998a) 
1032-1033.  
 
[38] Kuska, B. The semantics of junk DNA. J Natl Cancer Inst 90, (1998b) 2215-1127.  
 
[39] Larsen, F. et al. CpG islands as gene markers in the human genome. Genomics 13, (1992) 
1095-1107. 
 
[40] Lewis, B. P. et al. Evidence for the widespread coupling of alternative splicing and 
nonsense-mediated mRNA decay in humans. Proc Natl Acad Sci U S A 100, (2003) 189-192. 
 
[41] Luque, T. et al. Characterization and molecular analysis of Adh retrosequences in species 
of the Drosophila obscura group. Mol Biol Evol 14, (1997) 1316-1325. 
 
[42] Lynch, M., and A. Force. The probability of duplicate gene preservation by 
subfunctionalization. Genetics 154, (2000) 459-473. 
 
[42] Mango, S. F., et al. Carboxy-terminal truncation activates glp-1 protein. Nature 352, (1991) 
811-815. 
 
[43] Max, E. E. Plagiarized errors and molecular genetics. http://www.talkorigins.org/faqs/molgen/. 
March 19, 2002. 
 
[44] Meireles, C. M. The tarsius γ-globin gene: pseudogene or active gene? Mol Phylogenet Evol 
13, (1999) 434-439. 
 
[45] Mezzina, M. et al. Characterization of the mtTFA gene and identification of a processed 
pseudogene in rat. Gene 286 (2002) 111. 
 
[46] Mighell, A. J., et al. Vertebrate pseudogenes.  FEBS Lett 468, (2000) 109-114. 
 
[47] Modrek, B., et al. Genome-wide detection of alternative splicing in expressed sequences of 
human genes. Nucleic Acids Res 29, (2001) 2850-2859. 
 
[48] Morgan, K., et. al. A transcriptionally active human type II gonadotropiin-releasing hormore 
receptor gene homolog. Endocrinology 144, (2003) 423-436. 
 
[49] Mounsey, A. et al. Evidence suggesting that a fifth of annotated Caenorhabditis elegans 
genes may be pseudogenes. Genome Res 12, (2002) 770-775. 
 
[50} Mullick, J., et al. Localization of a transcription promoter within the second exon of the 
cytochrome P-450c27/25 gene. Biochemistry 34, (1995) 13729-13742. 
 
[51] Ohno, S. So much “junk” in our genome.  Brookhaven Symp Biol 23 (1972) 366-370. 
 
[52] Pugh, B. F., and R. Tijan. Diverse transcriptional functions of the multisubunit eukaryotic 
TFIID complex. J Biol Chem 267, (1992) 679-682. 
 
[53] Ramos-Onsins, S., and M. Aguade. Molecular evolution of the Cecropin multigene family in 
Drosophila. Genetics 150, (1998) 157-171.  
 
[54] Reisman, D,. A novel transcript encoded within the 10-kb first intron of the human p53 
tumor suppressor gene. Genomics 38, (1996) 364-370.  
 
[55] Resnick, M. A., and B. S. Cox. Yeast as an honorary mammal. Mutat Res 451, (2000) 1-11. 
 
[56] Reyes, A., et al. Human mitochrondrial transcription factor A (mtTFA): gene structure and 
characterization of related pseudogenes. Gene 291 (2002) 223-232. 
 
 514
[57] Rhodes, K., and R. G. Oshima. A regulatory element of the human keratin 18 gene. J Biol 
Chem 273, (1998), 26534-26542. 
 
[58] Robinson, D. N., and L. Cooley. Examination of the function of two kelch proteins generated 
by stop codon suppression. Development 124, (1997) 1405-1417. 
 
[59] Seroussi, E., Uniquely conserved non-translated regions are involved in the generation of 
the two major transcripts of protein phosphatase 2Cβ . J Mol Biol 312, (2001) 439-451. 
 
[60] Singer, V. L., et al. A wide variety of DNA sequences can functionally replace a yeast TATA 
element for transcriptional activation. Genes Dev 4, (1990) 636-645. 
 
[61] Srinivasan, G. et al. Pyrrolysine encoded by UAG in Archaea. Science 296, (2002) 1459-1462. 
 
[62] Steneberg, P., and C. Samakovlis. A novel stop codon readthrough mechanism produces 
functional Headcase protein in Drosophila  trachea. EMBO Rep 2, (2001) 593-597. 
 
[63] Szeverenyi, I., et al. Vector for IS element entrapment and functional characterization based 
on turning on expression of distal promoterless genes. Gene 174, (1996) 103-110. 
 
[64] Terrinoni, A., et al. Cyclin D1 gene contains a cryptic promoter. Genes, Chromosomes, and 
Cancer 31, (2001) 209-220. 
 
[65] True, H. L., and S. L. Lindquist. A yeast prion provides a mechanism for genetic variation 
and phenotypic diversity. Nature 407, (2000) 477-483. 
 
[66] Viklund, L., et al. Expression and characterization of minican, a recombinant syndecan-1 
with extensively truncated core protein. Biochem Biophys Res Commun 290, (2002) 146-152. 
 
[67] Wang, Y., Zhang, C.-T., and P. Dong. Recognizing shorter coding regions of human genes 
based on the statistics of stop codons. Biopolymers 63, (2002) 207-216. 
 
[68] Wieczorek, E. et al. Function of TAFII-containing complex without TBP in transcription by 
RNA polymerase II. Nature 393, (1998) 187-191. 
 
[69] Wiley, S., R. et al. Functional binding of the “TATA” box binding component of 
transcription factor TFIID to the –30 region of TATA-less promoters. Proc Natl Acad Sci U S 
A 89, (1992) 5814-5818. 
 
[70] Woodmorappe, J. Are pseudogenes “shared mistakes’” between primate genomes? 
Creation Ex Nihilo Technical Journal 14, No. 3 (2000) 55-71. 
 
[71] Woodmorappe, J. Pseudogene function: Regulation of gene expression. Creation Ex Nihilo 
Technical Journal  21, (2003) in press. 
 
[72] Yeh, R.F., Lim, L. P., and C. B. Burge. Computational inference of homologous gene 
structures in the human genome. Genome Res, 11 (2001) 803-816. 
 
[73] Yi, P. et al. Bcl-rambo beta, a special splicing variant with an insertion of an Alu-like 
cassette. FEBS Lett 534, (2003) 61-68. 
 
[74] Yousef, G. M. et al. Genomic organization of the siglec gene locus on chromosome 19q13.4 
and cloning of two new siglec pseudogenes. Gene 286, (2002) 259-270. 
 
[75] Zhang, B., and J.-T. Zhang. Regulation of gene expression by internal ribosome entry sites 
or cryptic promoters. Mol Cell Biol, 22 (2002) 7372-7384. 
 
[76] Zhi, N. et. al. Activation of a p44 pseudogene in Anaplasma phagocytophila by bacterial 
RNA splicing. Mol Microbiol 46, (2002) 135-145. 
 
